伊曲康唑继发的紫癜性药疹。 - Suppr

Suppr

超能文献

Purpuric drug eruption secondary to itraconazole.

作者信息

Kramer K E, Yaar M, Andersen W

机构信息

Department of Dermatology, Boston University School of Medicine, MA, USA.

出版信息

J Am Acad Dermatol. 1997 Dec;37(6):994-5. doi: 10.1016/s0190-9622(97)70080-x.

DOI:10.1016/s0190-9622(97)70080-x

PMID:9418771

Abstract

摘要

相似文献

Purpuric drug eruption secondary to itraconazole.

J Am Acad Dermatol. 1997 Dec;37(6):994-5. doi: 10.1016/s0190-9622(97)70080-x.

Iatrogenic metrorrhagia after the use of itraconazole for onychomycosis.

Indian J Pharmacol. 2017 Nov-Dec;49(6):470-471. doi: 10.4103/ijp.IJP_838_16.

Liver failure and transplantation after itraconazole treatment for toenail onychomycosis.

J Eur Acad Dermatol Venereol. 2005 Mar;19(2):205-7. doi: 10.1111/j.1468-3083.2005.00943.x.

Maculopapular eruption secondary to itraconazole.

Coll Antropol. 2008 Jun;32(2):649-51.

The use of itraconazole to treat cutaneous fungal infections in children.

Dermatology. 1999;199(3):248-52. doi: 10.1159/000018256.

Severe erythema anulare centrifugum-like psoriatic drug eruption induced by terbinafine.

Arch Dermatol. 1995 Aug;131(8):960-1. doi: 10.1001/archderm.131.8.960.

Onychomycosis. New therapies for an old disease.

West J Med. 1996 Dec;165(6):349-51.

Fixed drug eruption due to itraconazole: a rare occurence.

Postgrad Med J. 2019 Jun;95(1124):340-341. doi: 10.1136/postgradmedj-2019-136680. Epub 2019 May 13.

A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.

Int J Dermatol. 2005 Sep;44(9):785-8. doi: 10.1111/j.1365-4632.2004.02117.x.

Exacerbation of systemic lupus erythematosus induced by terbinafine.

Br J Dermatol. 1998 Dec;139(6):1133. doi: 10.1046/j.1365-2133.1998.2576r.x.

引用本文的文献

Itraconazole-associated purpuric drug eruption: a rare adverse effect of a commonly prescribed drug.

Skin Health Dis. 2025 Mar 21;5(2):148-150. doi: 10.1093/skinhd/vzaf006. eCollection 2025 Apr.

Global Dermatophyte Infections Linked to Human and Animal Health: A Scoping Review.

Microorganisms. 2025 Mar 3;13(3):575. doi: 10.3390/microorganisms13030575.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Purpuric drug eruption secondary to itraconazole.

J Am Acad Dermatol. 1997 Dec;37(6):994-5. doi: 10.1016/s0190-9622(97)70080-x.

Iatrogenic metrorrhagia after the use of itraconazole for onychomycosis.

Indian J Pharmacol. 2017 Nov-Dec;49(6):470-471. doi: 10.4103/ijp.IJP_838_16.

Liver failure and transplantation after itraconazole treatment for toenail onychomycosis.

J Eur Acad Dermatol Venereol. 2005 Mar;19(2):205-7. doi: 10.1111/j.1468-3083.2005.00943.x.

Maculopapular eruption secondary to itraconazole.

Coll Antropol. 2008 Jun;32(2):649-51.

The use of itraconazole to treat cutaneous fungal infections in children.

Dermatology. 1999;199(3):248-52. doi: 10.1159/000018256.

Severe erythema anulare centrifugum-like psoriatic drug eruption induced by terbinafine.

Arch Dermatol. 1995 Aug;131(8):960-1. doi: 10.1001/archderm.131.8.960.

Onychomycosis. New therapies for an old disease.

West J Med. 1996 Dec;165(6):349-51.

Fixed drug eruption due to itraconazole: a rare occurence.

Postgrad Med J. 2019 Jun;95(1124):340-341. doi: 10.1136/postgradmedj-2019-136680. Epub 2019 May 13.

A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.

Int J Dermatol. 2005 Sep;44(9):785-8. doi: 10.1111/j.1365-4632.2004.02117.x.

Exacerbation of systemic lupus erythematosus induced by terbinafine.

Br J Dermatol. 1998 Dec;139(6):1133. doi: 10.1046/j.1365-2133.1998.2576r.x.

引用本文的文献

Itraconazole-associated purpuric drug eruption: a rare adverse effect of a commonly prescribed drug.

Skin Health Dis. 2025 Mar 21;5(2):148-150. doi: 10.1093/skinhd/vzaf006. eCollection 2025 Apr.

Global Dermatophyte Infections Linked to Human and Animal Health: A Scoping Review.

Microorganisms. 2025 Mar 3;13(3):575. doi: 10.3390/microorganisms13030575.